2Johnson AT, Kaufmann Y, Luo S, et al. Gut glutathione me- tabolism and changes with 7, 12-DMBA and giutamine. J Surg Res, 2003,115 : 242-246.
3Kirby DF, Teran JC. Enteral feeding in critical care, gastrointes- tinal disease, and cancer. Gastrointest Endosc Clin North Am, 1991, 77:623-634.
4Page CP. Continual catheter administration of an elemental diet. Surg Gynecol Obstet, 1976, 142:184.
5Hochwald SN, Harrison LE, Heslin MJ, et al. Early postopera- tive enteral feeding improves whole body protein kinetics in upper gastrointestinal cancer patients. Am J Surg, 1997,174: 325-330.
6Huckleberry Y. Nutritional support and the surgical patient. Am J Health Syst Pharm, 2004, 61:671-682.
7Daly J M, Weintraub F N, Shou J,et al. Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients[J].Ann Surg,1995,221(4):327-338.
8Baskln W N. Advances in enteral nutrition techniques[J]. Am J Gastroenterol, 1992,87( 11 ):1547-1553.
9Decker D, Schondorf M, Bidlingmaier F, et al. Surgical stress induces a shift in the type-1/type 2 T-helper cell balance, suggesring down-regulation of cell-mediated and up-regulation ofantibody-mediated immunity commensurate to the trauma[J].Surgery, 1996,119(3):316-325.
10Tashiro T, Yamamori H, Takagi K, et al. Changes in immune function following surgery for esophageal carcinoma[J]. Nutrition, 1999,15(10) :760-766.
1Gabitass RF, Annels NE,Stocken DD, et al. Elevated myeloid- derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13[J]. Cancer Immunol Immunother, 2011,60 (10) : 1419-1430.
2Keeley BR,Islami F, Pourshams A,et al. Prediagnostic serum levels of inflammatory biomarkers are correlated with future de- velopment of lung and esophageal cancer[J]. Cancer Sci,2014, 105 (9) : 1205-1211.
